Guidelines for hormone treatment of women in the menopausal transition and beyond

Recent communications regarding estrogen or estrogen + progestin treatment and clinical cardioprotection, breast cancer risk, and cerebral aging have produced considerable confusion and concerns among women, care-givers, and the media. Guidelines for hormone treatment of women in the menopausal tran...

Full description

Saved in:
Bibliographic Details
Published in:Climacteric : the journal of the International Menopause Society 2004-12, Vol.7 (4), p.333-337
Main Authors: Naftolin, F, Schneider, H P G, Sturdee, D W, Birkhäuser, M, Brincat, M P, Gambacciani, M, Genazzani, A R, Limpaphayom, K K, O'Neill, S, Palacios, S, Pines, A, Siseles, N, Tan, D, Burger, H G
Format: Article
Language:English
Subjects:
Cardiovascular Diseases - prevention & control
Cerebrovascular Disorders - prevention & control
Dose-Response Relationship, Drug
Endometrial Neoplasms - prevention & control
Estrogen Replacement Therapy - standards
Female
Guidelines
Hormone replacement therapy
Humans
Menopause
Menopause - physiology
Osteoporosis, Postmenopausal - prevention & control
Randomized Controlled Trials as Topic
Women
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent communications regarding estrogen or estrogen + progestin treatment and clinical cardioprotection, breast cancer risk, and cerebral aging have produced considerable confusion and concerns among women, care-givers, and the media. Guidelines for hormone treatment of women in the menopausal transition and beyond are presented.
ISSN:1369-7137
1473-0804
DOI:10.1080/13697130400014615